GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (WBO:VLAP.PFD) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

Valneva SE (WBO:VLAP.PFD) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.


Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (WBO:VLAP.PFD) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.